Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin

被引:316
|
作者
Chan, Siew Wee [1 ]
Lim, Chun Jye [1 ]
Chong, Yaan Fun [1 ]
Pobbati, Ajaybabu V. [1 ]
Huang, Caixia [1 ]
Hong, Wanjin [1 ,2 ]
机构
[1] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore
[2] Natl Univ Singapore, Dept Biochem, Singapore 119077, Singapore
关键词
YES-ASSOCIATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; WW DOMAIN; ONCOGENIC TRANSFORMATION; GROWTH-CONTROL; TRANSCRIPTION; BINDING; CANCER;
D O I
10.1074/jbc.C110.212621
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Hippo pathway restricts the activity of transcriptional co-activators TAZ and YAP by phosphorylating them for cytoplasmic sequestration or degradation. In this report, we describe an independent mechanism for the cell to restrict the activity of TAZ and YAP through interaction with angiomotin (Amot) and angiomotin-like 1 (AmotL1). Amot and AmotL1 were robustly co-immunoprecipitated with FLAG-tagged TAZ, and their interaction is dependent on the WW domain of TAZ and the PPXY motif in the N terminus of Amot. Amot and AmotL1 also interact with YAP via the first WW domain of YAP. Overexpression of Amot and AmotL1 caused cytoplasmic retention of TAZ and suppressed its transcriptional outcome such as the expression of CTGF and Cyr61. Hippo refractory TAZ mutant (S89A) is also negatively regulated by Amot and AmotL1. HEK293 cells express the highest level of Amot and AmotL1 among nine cell lines examined, and silencing the expression of endogenous Amot increased the expression of CTGF and Cyr61 either at basal levels or upon overexpression of exogenous S89A. These results reveal a novel mechanism to restrict the activity of TAZ and YAP through physical interaction with Amot and AmotL1.
引用
收藏
页码:7018 / 7026
页数:9
相关论文
共 50 条
  • [41] Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers
    Luo, Mengxin
    Xu, Yongjin
    Chen, Haifeng
    Wu, Yiquan
    Pang, Ao
    Hu, Junjie
    Dong, Xiaowu
    Che, Jinxin
    Yang, Haiyan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
  • [42] Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
    Moya, Ivan M.
    Castaldo, Stephanie A.
    Van den Mooter, Laura
    Soheily, Soheil
    Sansores-Garcia, Leticia
    Jacobs, Jelle
    Mannaerts, Inge
    Xie, Jun
    Verboven, Elisabeth
    Hillen, Hanne
    Alguero-Nadal, Ana
    Karaman, Ruchan
    Van Haele, Matthias
    Kowalczyk, Weronika
    De Waegeneer, Maxime
    Verhulst, Stefaan
    Karras, Panagiotis
    van Huffel, Leen
    Zender, Lars
    Marine, Jean-Christophe
    Roskams, Tania
    Johnson, Randy
    Aerts, Stein
    van Grunsven, Leo A.
    Halder, Georg
    SCIENCE, 2019, 366 (6468) : 1029 - 1034
  • [43] Angiomotin to regulate prostate cancer cell proliferation by signaling through Hippo-YAP pathway.
    Shen, Pengfei
    Zeng, Hao
    Ortiz, Angelica
    Cheng, Chien-Jui
    Lee, Yu-Chen
    Yu, Guoyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [44] Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders
    Han, Juanjuan
    Zhang, Jiale
    Zhang, Xiaoyi
    Luo, Wenxin
    Liu, Lifei
    Zhu, Yuqing
    Liu, Qingfeng
    Zhang, Xin-an
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
  • [45] Distinct effects of Hippo-YAP/TAZ and YAP/TAZ-TEAD in epithelial maintenance and repair
    Yuan, Qiuyun
    Yuan, Yao
    Peng, Yang
    Xia, Xiaoqiang
    Chen, Qianming
    Yu, Fa-Xing
    Feng, Xiaodong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 751
  • [46] Hippo-Yap/Taz signalling in zebrafish regeneration
    Riley, Susanna E.
    Feng, Yi
    Hansen, Carsten Gram
    NPJ REGENERATIVE MEDICINE, 2022, 7 (01)
  • [47] Hippo-Yap/Taz signalling in zebrafish regeneration
    Susanna E. Riley
    Yi Feng
    Carsten Gram Hansen
    npj Regenerative Medicine, 7
  • [48] Cysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ
    Prem Khanal
    Zongchao Jia
    Xiaolong Yang
    Scientific Reports, 8
  • [49] Core Hippo pathway components act as a brake on Yap and Taz in the development and maintenance of the biliary network
    Brandt, Zachary J.
    Echert, Ashley E.
    Bostrom, Jonathan R.
    North, Paula N.
    Link, Brian A.
    DEVELOPMENT, 2020, 147 (12):
  • [50] Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
    Dobrokhotov, Oleg
    Samsonov, Mikhail
    Sokabe, Masahiro
    Hirata, Hiroaki
    CLINICAL AND TRANSLATIONAL MEDICINE, 2018, 7